Recombinant factor VIIa restores aggregation of αIIbβ 3-deficient platelets via tissue factor-independent fibrin generation

Blood

Volumn 103, Issue 5, 2004, Pages 1720-1727

  Lisman, Ton ^a   Adelmeijer, Jelle ^b   Heijnen, Harry F G ^b   De Groot, Philip G ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHAIIBBETA3 INTEGRIN; ARGINYLGLYCYLASPARTIC ACID; BLOOD CLOTTING FACTOR 10; FIBRIN; FIBRINOGEN; INTEGRIN; PEPTIDE; PROTHROMBIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; ELECTRON MICROSCOPY; FIBRIN FORMATION; FIBRIN POLYMERIZATION; GLANZMANN DISEASE; HEMOSTASIS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE AGGREGATION;

EID: 1442308083     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-07-2287     Document Type: Article

References (30)

1. French DL, Seligsohn U. Platelet glycoprotein IIb/IIIa receptors and Glanzmann's thrombasthenia. Arterioscler Thromb Vasc Biol. 2000;20:607-610.
2. Parise LV, Smyth SS, Coller BS. Platelet morphology, biochemistry and function. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U, eds. Williams Hematology. New York, NY: McGraw-Hill; 2001:1357-1408.
3. Poon MC, Demers C, Jobin F, Wu JW. Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia. Blood. 1999;94:3951-3953.
4. Poon MC, d'Oiron R, Hann I, et al. Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia. Semin Hematol. 2001;38:21-25.
5. Hedner U. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa. Thromb Haemost. 1999;82:531-539.
6. Lisman T, Mosnier LO, Lambert T, et al. Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe haemophilia A. Blood. 2002;99:175-179.
7. Butenas S, Brummel KE, Branda RF, Paradis SG, Mann KG. Mechanism of factor VIIa-dependent coagulation in hemophilia blood. Blood. 2002;99:923-930.
8. Butenas S, Brummel KE, Bouchard BA, Mann KG. How factor VIIa works in hemophilia. J Thromb Haemost. 2003;1:1158-1160.
9. van 't Veer C, Golden NJ, Mann KG. Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa. Blood. 2000;95:1330-1335.
10. Lisman T, Moschatsis S, Adelmeijer J, Nieuwenhuis HK, de Groot PG. Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIbbeta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation. Blood. 2003;101:1864-1870.
11. Monroe DM, Hoffman M, Olivier JA, Roberts HR. Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol. 1997;99:542-547.
12. Hoffman M, Monroe DM, Roberts HR. Human monocytes support factor X activation by factor VIIa, independent of tissue factor: implications for the therapeutic mechanism of high-dose factor VIIa in hemophilia. Blood. 1994;83:38-42.
13. Lisman T, de Groot PG. Mechanism of action of recombinant factor VIIa. J Thromb Haemost. 2003;1:1138-1139.
14. Galan AM, Tonda R, Altisent C, Maragall S, Ordinas A, Escolar G. Recombinant factor VIIa (Novoseven) restores deficient coagulation: experience from an ex vivo model. Semin Hematol. 2001;38:10-14.
15. Torbet J. The thrombin activation pathway modulates the assembly, structure and lysis of human plasma clots in vitro. Thromb Haemost. 1995;73:785-792.
16. Carr ME Jr, Alving BM. Effect of fibrin structure on plasmin-mediated dissolution of plasma clots. Blood Coagul Fibrinolysis. 1995;6:567-573.
17. Galan AM, Tonda R, Pino M, Reverter JC, Ordinas A, Escolar G. Increased local procoagulant action: a mechanism contributing to the favorable hemostatic effect of recombinant FVIIa in PLT disorders. Transfusion. 2003;43:885-892.
18. Niewiarowski S, Levy-Toledano S, Caen JP. Platelet interaction with polymerizing fibrin in Glanzmann's thrombasthenia. Thromb Res. 1981;23:457-463.
19. McGregor L, Hanss M, Sayegh A, et al. Aggregation to thrombin and collagen of platelets from a Glanzmann thrombasthenic patient lacking glycoproteins IIb and IIIa. Thromb Haemost. 1989;62:962-967.
20. Soslau G, Class R, Morgan DA, et al. Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib. J Biol Chem. 2001;276:21173-21183.
21. Jarvis GE, Atkinson BT, Frampton J, Watson SP. Thrombin-induced conversion of fibrinogen to fibrin results in rapid platelet trapping which is not dependent on platelet activation of GPIb. Br J Pharmacol. 2003;138:574-583.
22. Osdoit S, Rosa JP. Polymeric fibrin interacts with platelets independently from integrin alphaIIb-beta3 [abstract]. Blood. 2001;98:518a.
23. Allain JP, Cooper HA, Wagner RH, Brinkhous KM. Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor. J Lab Clin Med. 1975;85:318-328.
24. Born GVR. Aggregation of blood platelets by adenosine/diphosphate and its reversal. Nature (Lond). 1962;194:927-929.
25. Hackeng TM, van 't Veer C, Meijers JC, Bouma BN. Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa. J Biol Chem. 1994;269:21051-21058.
26. Koedam JA, Meijers JC, Sixma JJ, Bouma BN. Inactivation of human factor VIII by activated protein C: cofactor activity of protein S and protective effect of von Willebrand factor. J Clin Invest. 1988;82:1236-1243.
27. Heynen HF, Lozano MM, de Groot PG, Nieuwenhuis HK, Sixma JJ. Absence of ligands bound to glycoprotein IIB-IIIA on the exposed surface of a thrombus may limit thrombus growth in flowing blood. J Clin Invest. 1994;94:1098-1112.
28. Sakariassen KS, Aarts PAMM, de Groot PG, Houdijk WPM, Sixma JJ. A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel walls, their extracellular matrix, and purified components. J Lab Clin Med. 1983;102:522-535.
29. Sixma JJ, de Groot PG, van Zanten H, IJsseldijk M. A new perfusion chamber to detect platelet adhesion using a small volume of blood. Thromb Res. 1998;92:S43-S46.
30. He S, Blomback M, Jacobsson Ekman G, Hedner U. The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX. J Thromb Haemost. 2003;1:1215-1219.